Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.95B |
| 2 |
NVIDIA
NVDA
|
+$1.63B |
| 3 |
Visa
V
|
+$1.09B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.05B |
| 5 |
Amazon
AMZN
|
+$917M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.48B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.36B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.06B |
| 4 |
iShares MSCI India ETF
INDA
|
+$827M |
| 5 |
iShares MBS ETF
MBB
|
+$767M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.58% |
| 2 | Consumer Discretionary | 2.07% |
| 3 | Financials | 1.9% |
| 4 | Healthcare | 1.47% |
| 5 | Industrials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6701
Evolv Technologies
EVLV
$1.08B
| $582K | ﹤0.01% |
228,158
+155,730
| +215% | +$516K |
|
6702
Goldman Sachs BDC
GSBD
$1.09B
| $582K | ﹤0.01% |
38,708
+142
| +0.4% | +$2.18K |
|
|
HSII
6703
DELISTED
Heidrick & Struggles
HSII
| $581K | ﹤0.01% |
+18,387
| New | +$599K |
|
6704
iShares US Technology ETF
IYW
$25.2B
| $581K | ﹤0.01% |
3,858
-5,959
| -61% | -$824K |
|
6705
PUT
Gray Television
GTN
$490M
| $580K | ﹤0.01% |
+111,500
| New | +$652K |
|
6706
CALL
Organon & Co
OGN
$3.58B
| $580K | ﹤0.01% |
28,000
-56,500
| -67% | -$1.12M |
|
|
HTBK
6707
DELISTED
Heritage Commerce
HTBK
| $579K | ﹤0.01% |
66,599
+29,711
| +81% | +$242K |
|
6708
TScan Therapeutics
TCRX
$50.8M
| $579K | ﹤0.01% |
99,036
-54,097
| -35% | -$426K |
|
6709
CALL
ADMA Biologics
ADMA
$2.22B
| $579K | ﹤0.01% |
51,800
+9,200
| +22% | +$77.2K |
|
|
DNMR
6710
DELISTED
Danimer Scientific, Inc.
DNMR
| $579K | ﹤0.01% |
23,981
+23,002
| +2,350% | +$715K |
|
6711
Nuveen ESG US Aggregate Bond ETF
NUBD
$464M
| $578K | ﹤0.01% |
26,500
-32,668
| -55% | -$707K |
|
6712
PUT
Qfin Holdings
QFIN
$1.56B
| $578K | ﹤0.01% |
+29,300
| New | +$575K |
|
|
WRK
6713
PUT
DELISTED
WestRock Company
WRK
| $578K | ﹤0.01% |
+11,500
| New | +$580K |
|
6714
PUT
Kinsale Capital Group
KNSL
$8.53B
| $578K | ﹤0.01% |
+1,500
| New | +$609K |
|
6715
VanEck Preferred Securities ex Financials ETF
PFXF
$2.45B
| $577K | ﹤0.01% |
+33,344
| New | +$578K |
|
6716
CALL
ATI
ATI
$31.3B
| $577K | ﹤0.01% |
+10,400
| New | +$583K |
|
6717
PUT
USA Compression Partners
USAC
$3.75B
| $577K | ﹤0.01% |
+24,300
| New | +$600K |
|
6718
Orthofix Medical
OFIX
$420M
| $577K | ﹤0.01% |
43,487
-43,162
| -50% | -$591K |
|
6719
Pulmonx
LUNG
$97.1M
| $576K | ﹤0.01% |
+90,866
| New | +$699K |
|
6720
BNY Mellon Emerging Markets Equity ETF
BKEM
$90.2M
| $576K | ﹤0.01% |
28,890
-23,169
| -45% | -$453K |
|
|
AD
6721
Array Digital Infrastructure
AD
$3.01B
| $576K | ﹤0.01% |
10,315
-7,037
| -41% | -$310K |
|
6722
John Hancock Dynamic Municipal Bond ETF
JHMU
$44.1M
| $576K | ﹤0.01% |
21,975
+543
| +3% | +$14.6K |
|
6723
ICL Group
ICL
$6.89B
| $576K | ﹤0.01% |
+133,217
| New | +$627K |
|
6724
Fidelity MSCI Financials Index ETF
FNCL
$2.41B
| $576K | ﹤0.01% |
+9,935
| New | +$575K |
|
6725
Xenon Pharmaceuticals
XENE
$6.11B
| $575K | ﹤0.01% |
14,755
+6,306
| +75% | +$252K |
|
Similar funds
Jane Street's Q2 2024 Portfolio in Review
As of Q2 2024, Jane Street held 10,566 positions worth $438B, down 8.5% from $478B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Jane Street withdrew a net $64.5B in Q2 2024, closing 1,331 positions and reducing 3,257 holdings. Its most notable exit was iShares MSCI EAFE Small-Cap ETF, an estimated $254M position sold in full.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jane Street opened a new position in iShares Bitcoin Trust worth $221M.
- Jane Street's largest Q2 2024 buy was iShares Bitcoin Trust: 6,474,742 shares worth $221M.
- Jane Street added most to Apple in Q2 2024, an estimated $2.95B increase.
- Jane Street's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.48B.
- Jane Street fully exited iShares MSCI EAFE Small-Cap ETF in Q2 2024, selling an estimated $254M.
- Jane Street's ten largest holdings make up 43% of its $438B portfolio in Q2 2024.
- Jane Street opened 1,468 new positions and closed 1,331 in Q2 2024.
- Jane Street's portfolio value fell 8.5% quarter-over-quarter to $438B.
Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.